Baron Health Care Fund Q1 2026 Portfolio Activity
Natera Inc NTRA
$203.11
▲ +1.10%
(+$2.20)
Open
$200.52
Prev Close
$200.91
Day Range
$196.44 – $204.64
52W Range
$131.81 – $256.36
Market Cap
$29.09B
Beta
1.55
EPS (TTM)
$-1.64
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2015-07-02 |
| Shares Out. | 143,220,000 |
| Website | natera.com/ ↗ |
| Phone | 13026587581 |
Natera Inc is a publicly traded company under the ticker symbol NTRA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
28 analysts (2026-05-01)
📰 Latest News for NTRA
Natera: A Growing Biotech, After Recent FDA Approval And Q1 Revenue Results
Natera Enhances Its Panorama Non-Invasive Prenatal Test, Adding Clinically-Validated Performance Data
If You Invested $1000 In Natera Stock 10 Years Ago, You Would Have This Much Today
Natera Expands North Austin HQ With New Sequencing Facility And Added Space, Boosting Capacity Amid 54% Oncology Volume Growth
Natera Announces That Its EXPAND Clinical Trial Has Enrolled Over 2,000 Patients, More Than Doubling Enrollment In The Last 12 Months
Natera Gets FDA Approval for Bladder-Cancer Test
Natera Receives FDA Approval For Signatera CDx As Companion Diagnostic For Use With Adjuvant Atezolizumab Immunotherapy In Muscle-Invasive Bladder Cancer